Company-level financial information
HCA Healthcare, Inc.
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 12,636.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 6,784.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Total cash dividends | 679.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 4,944.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 10,514.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 5,760.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Total cash dividends | 690.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 4,875.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 9,431.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 5,242.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Total cash dividends | 661.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 4,744.0 | SEC filingFeb 10, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 8,522.0 | SEC filingFeb 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 5,643.0 | SEC filingFeb 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Total cash dividends | 653.0 | SEC filingFeb 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 4,395.0 | SEC filingFeb 14, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 8,959.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 6,956.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Total cash dividends | 624.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 3,577.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 9,232.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 3,754.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Total cash dividends | 153.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 2,835.0 | SEC filingFeb 17, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 7,602.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 3,505.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Total cash dividends | 550.0 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 4,158.0 | SEC filingFeb 18, 2022 |